ArticleMediterranean journal of hematology and infectious diseases2021

Venetoclax-Rituximab Treatment of Relapsed/Refractory CLL During the COVID-19 Pandemic: A Real-Life Experience in Selected Central-Southern Italian Regions.

Stefano Molica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.